STRATEC DEVELOPMENT AGREEMENTStratec Development Agreement • March 26th, 2014 • Quotient LTD • In vitro & in vivo diagnostic substances
Contract Type FiledMarch 26th, 2014 Company IndustryTHIS STRATEC DEVELOPMENT AGREEMENT is effective as of January 7th, 2014 (the “Effective Date”) and Is made by and between STRATEC Biomedical AG, a stock corporation formed under the laws of the Federal Republic of Germany, having its principal place of business at Gewerbestrasse 37, D-75217 Birkenfeld-Graefenhausen, Germany (hereinafter referred to as “STRATEC”), and QBD (QS IP) Ltd, having its registered office at PO Box 1075, Elizabeth House, 9 Castle Street, St Helier JE4 2QP, Jersey, Channel Islands (hereinafter referred to as “QUOTIENT”, and both STRATEC and QUOTIENT are referred to as the Parties
STRATEC DEVELOPMENT AGREEMENTStratec Development Agreement • March 7th, 2014 • Quotient LTD • In vitro & in vivo diagnostic substances
Contract Type FiledMarch 7th, 2014 Company IndustryTHIS STRATEC DEVELOPMENT AGREEMENT is effective as of January 7th, 2014 (the “Effective Date”) and Is made by and between STRATEC Biomedical AG, a stock corporation formed under the laws of the Federal Republic of Germany, having its principal place of business at Gewerbestrasse 37, D-75217 Birkenfeld-Graefenhausen, Germany (hereinafter referred to as “STRATEC”), and QBD (QS IP) Ltd, having its registered office at PO Box 1075, Elizabeth House, 9 Castle Street, St Helier JE4 2QP, Jersey, Channel Islands (hereinafter referred to as “QUOTIENT”, and both STRATEC and QUOTIENT are referred to as the Parties
STRATEC DEVELOPMENT AGREEMENTStratec Development Agreement • April 3rd, 2014 • Quotient LTD • In vitro & in vivo diagnostic substances
Contract Type FiledApril 3rd, 2014 Company IndustryTHIS STRATEC DEVELOPMENT AGREEMENT is effective as of January 7th, 2014 (the “Effective Date”) and Is made by and between STRATEC Biomedical AG, a stock corporation formed under the laws of the Federal Republic of Germany, having its principal place of business at Gewerbestrasse 37, D-75217 Birkenfeld-Graefenhausen, Germany (hereinafter referred to as “STRATEC”), and QBD (QS IP) Ltd, having its registered office at PO Box 1075, Elizabeth House, 9 Castle Street, St Helier JE4 2QP, Jersey, Channel Islands (hereinafter referred to as “QUOTIENT”, and both STRATEC and QUOTIENT are referred to as the Parties